Pabrinex shortage and guidance on alternatives
Pabrinex IV will be out of stock from July/ August 2024 until September 2025, due to supply issues relating to manufacturing regulations issued by the EU. Pabrinex IM will be permanently discontinued from December 2024. Pabrinex is only used in the UK, with thiamine IV/ IM being routinely used globally.
It is important to note if a Patient Group Direction (PGD) is being used (often used in community setting), only licensed products can be used in this setting. Therefore IM Pabrinex should be conserved for this purpose.
The following has been published online by the DHSC Specialist Pharmacy Service.
Joanna Henry, Gastroenterology Directorate Pharmacist, Liverpool University Hospitals NHS Trust
Sital Shah, Chair British Hepatology Pharmacy Group , Consultant Pharmacist, King’s College Hospital, London
BSG Hepatology Travelling Fellowship – EASL and Experience at a DGH Hepatology Unit
This fellowship aims to offer the opportunity for a junior trainee (IMT1, 2, 3 or ST4) who has yet to obtain an NTN, but has an interest in hepatology, to attend the EASL Congress in Amsterdam from 07-10 May 2025, to see the latest research and clinical updates in Hepatology.
HCC - Improving liver cancer surveillance in the UK
This channel presents video extracts from a meeting on "Improving hepatocellular carcinoma surveillance" held in Birmingham UK, April 2024. The meeting was supported by the British Association for Study of Liver (BASL) and the British Society of Gastroenterology (BSG). The aim of the meeting was discuss/showcase existing initiatives and new ideas for improving liver cancer surveillance in the UK.
Summer '24: The year for liver
It is shocking to realise that I have been the VP of Hepatology for a whole year. It has been a very interesting 12 months, and I am still honoured to be in this position.